101. IL22/IL-22R Pathway Induces Cell Survival in Human Glioblastoma Cells
- Author
-
Amazigh Abbaci, Lucie Karayan-Tapon, Marie-Odile Jauberteau, Sandrine Charreau, Karline Guilloteau, Fabrice Lalloué, Linda Domballe, Jean-Claude Lecron, Hussein Akil, Barbara Bessette, Léa M. M. Costes, Franck Morel, François-Xavier Bernard, Homéostasie Cellulaire et Pathologies (HCP), Université de Limoges (UNILIM)-CHU Limoges-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503), Laboratoire Inflammation, Tissus épithéliaux et Cytokines (LITEC), Université de Poitiers, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Laboratoire de neurosciences expérimentales et cliniques (LNEC), Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Limoges, and Morel, Franck
- Subjects
STAT3 Transcription Factor ,Cell signaling ,Cell Survival ,MAP Kinase Signaling System ,medicine.medical_treatment ,[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,lcsh:Medicine ,Gene Expression ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Biology ,[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Cell Line, Tumor ,medicine ,Humans ,Phosphorylation ,lcsh:Science ,Protein kinase B ,[SDV.IMM.II] Life Sciences [q-bio]/Immunology/Innate immunity ,PI3K/AKT/mTOR pathway ,Cell Proliferation ,Multidisciplinary ,Cell growth ,Interleukins ,lcsh:R ,[SDV.NEU.NB] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,Receptors, Interleukin ,Interleukin-10 Receptor beta Subunit ,Molecular biology ,3. Good health ,Cytokine ,[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology ,Cell culture ,[SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology ,Cancer cell ,Neoplastic Stem Cells ,Cancer research ,lcsh:Q ,Signal transduction ,Glioblastoma ,Proto-Oncogene Proteins c-akt ,Research Article ,Signal Transduction - Abstract
International audience; Interleukin-22 (IL-22) is a member of the IL-10 cytokine family that binds to a heterodimeric receptor consisting of IL-22 receptor 1 (IL-22R1) and IL-10R2. IL-22R expression was initially characterized on epithelial cells, and plays an essential role in a number of inflammato-ry diseases. Recently, a functional receptor was detected on cancer cells such as hepatocarcinoma and lung carcinoma, but its presence was not reported in glioblastoma (GBM). Two GBM cell lines and 10 primary cell lines established from patients undergoing surgery for malignant GBM were used to investigate the expression of IL-22 and IL-22R by using quantitative RT-PCR, western blotting and confocal microscopy studies. The role of IL-22 in proliferation and survival of GBM cell lines was investigated in vitro by BrdU and ELISA cell death assays. We report herein that the two subunits of the IL-22R complex are expressed on human GBM cells. Their activation, depending on exogenous IL-22, induced antiapoptotic effect and cell proliferation. IL-22 treatment of GBM cells resulted in increased levels of phosphorylated Akt, STAT3 signaling protein and its downstream antiapoptotic protein Bcl-xL and decreased level of phosphorylated ERK1/2. In addition, IL-22R subunits were expressed in all the 10 tested primary cell lines established from GBM tumors. Our results showed that IL-22R is expressed on GBM established and primary cell lines. Depending on STAT3, ERK1/2 and PI3K/Akt pathways, IL-22 induced GBM cell survival. These data are consistent with a potential role of IL-22R in tumorigenesis of GBM. Since endoge-nous IL-22 was not detected in all studied GBM cells, we hypothesize that IL-22R could be activated by immune microenvironmental IL-22 producing cells.
- Published
- 2015
- Full Text
- View/download PDF